speb/financial-data huggingface dataset:
Financial ratios for PALI — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -2922000
Net income: -2868000
Capital expenditures: 0
Operating cash flow: -3553000
Depreciation & amortization: 1000
Net tangible assets: 3212000
Owner earnings: -2867000
Return on net tangible assets (%): -89.2590286425903
Buffett classification: The Gruesome
Stock price: 0.86
Shares outstanding: 173579670
Book value: 3212000
P/B ratio: 46.47525410958904
Market cap (USD): 149278516.2
Debt to equity: 0.06569115815691158
Current ratio: 1.9631972397929844
Quick ratio: 1.9631972397929844
Interest coverage ratio: -584.4
Free cash flow (dilution-adjusted): -3643000
Buyback yield (%): 0
Retained earnings: -143826000
Receivables turnover: 0
Capitalized R&D asset: 2829750
ROCI (R&D-adjusted, %): -45.34039553605545
Rule of 40 score: 0
Financial ratios for PALI — annual report dated 2025-12-31
Total revenue: 0
Operating income: -18056000
Net income: -16781000
Capital expenditures: 0
Operating cash flow: -10847000
Depreciation & amortization: 3000
Net tangible assets: 129380000
Owner earnings: -16778000
Return on net tangible assets (%): -12.968001236667181
Buffett classification: The Gruesome
Stock price: 2.35
Shares outstanding: 173579670
Book value: 129380000
P/B ratio: 3.152822882207451
Market cap (USD): 407912224.5
Debt to equity: 0.0005487710619879425
Current ratio: 28.951898188093185
Quick ratio: 28.951898188093185
Interest coverage ratio: -1805.6
Free cash flow (dilution-adjusted): -14802000
Buyback yield (%): 0
Retained earnings: -152725000
Receivables turnover: 0
Capitalized R&D asset: 18538900
ROCI (R&D-adjusted, %): -11.18404499520732
Rule of 40 score: 0
Financial ratios for PALI — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -9981000
Net income: -8899000
Capital expenditures: 0
Operating cash flow: -3144000
Depreciation & amortization: 0
Net tangible assets: 129380000
Owner earnings: -8899000
Return on net tangible assets (%): -6.878188282578451
Buffett classification: The Gruesome
Stock price: 2.35
Shares outstanding: 173579670
Book value: 129380000
P/B ratio: 3.152822882207451
Market cap (USD): 407912224.5
Debt to equity: 0.0005487710619879425
Current ratio: 28.951898188093185
Quick ratio: 28.951898188093185
Interest coverage ratio: -4990.5
Free cash flow (dilution-adjusted): -6871000
Buyback yield (%): 0
Retained earnings: -152725000
Receivables turnover: 0
Capitalized R&D asset: 7659730
ROCI (R&D-adjusted, %): -5.014763413988618
Rule of 40 score: 0
Financial ratios for PRLB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 51.35
Shares outstanding: 23794045
Market cap (USD): 1221824210.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRLB — annual report dated 2022-12-31
Total revenue: 488398000
Gross profit: 215465000
Operating income: 26947000
Net income: -103462000
Capital expenditures: 17578000
Operating cash flow: 62079000
Depreciation & amortization: 39425000
Net tangible assets: 392407000
Owner earnings: -81615000
Return on net tangible assets (%): -20.798558639371876
Capex to operating income (%): 65.23175121534864
Buffett classification: The Good
Stock price: 25.53
Shares outstanding: 23794045
Book value: 697648000
P/B ratio: 0.8707284602693622
Market cap (USD): 607461968.85
Debt to equity: 0.030607125656491527
Current ratio: 2.606389963817214
Quick ratio: 2.4167027563180175
COGS to revenue (%): 55.883316475497445
R&D to revenue (%): 7.825994373441332
SG&A to revenue (%): 30.773262789773913
Free cash flow (dilution-adjusted): 22848000
Buyback yield (%): 5.159335334083935
Retained earnings: 258236000
Inventory turnover: 20.101119457946677
Receivables turnover: 6.084667422477481
Capitalized R&D asset: 38222000
ROCI (R&D-adjusted, %): 6.819422422647671
FCF margin (%): 4.6781518351836
Rule of 40 score: 4.6781518351836
Financial ratios for PRLB — annual report dated 2023-12-31
Total revenue: 503877000
Gross profit: 221993000
Operating income: 28382000
Net income: 17220000
Capital expenditures: 27417000
Operating cash flow: 73274000
Depreciation & amortization: 37528000
Net tangible assets: 395720000
Owner earnings: 27331000
Return on net tangible assets (%): 6.906651167492166
Capex to operating income (%): 96.59995771968148
Buffett classification: The Gruesome
Stock price: 38.96
P/E ratio: 53.83368137049942
Shares outstanding: 23794045
Book value: 695295000
P/B ratio: 1.3332700410617075
Market cap (USD): 927015993.2
Debt to equity: 0.007887299635406554
Current ratio: 4.038968619794288
Quick ratio: 3.764074797206175
Effective tax rate (%): 38.3943903835146
COGS to revenue (%): 55.94301783967119
R&D to revenue (%): 7.965237548052402
SG&A to revenue (%): 30.459020753080612
Free cash flow (dilution-adjusted): 29169000
Buyback yield (%): 4.896032035361868
Retained earnings: 256398000
Inventory turnover: 20.640257743281833
Receivables turnover: 6.711558953593692
Capitalized R&D asset: 65743740
ROCI (R&D-adjusted, %): 5.377619680702975
Rosenberg metric: 0.17079169064936425
FCF margin (%): 5.788912770378485
Revenue growth (%): 3.1693413977944216
Rule of 40 score: 8.958254168172907
Financial ratios for PRLB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.37
Shares outstanding: 23794045
Market cap (USD): 698831101.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRLB — annual report dated 2024-12-31
Total revenue: 500890000
Gross profit: 223200000
Operating income: 25496000
Net income: 16593000
Capital expenditures: 9135000
Operating cash flow: 77829000
Depreciation & amortization: 35808000
Net tangible assets: 374738000
Owner earnings: 43266000
Return on net tangible assets (%): 11.545666572378568
Capex to operating income (%): 35.82914967053655
Buffett classification: The Good
Stock price: 39.09
P/E ratio: 56.05431320737661
Shares outstanding: 23794045
Book value: 670151000
P/B ratio: 1.387909917391752
Market cap (USD): 930109219.0500001
Debt to equity: 0.0052465787561310805
Current ratio: 3.6577875391864243
Quick ratio: 3.4267988211221865
Effective tax rate (%): 32.74562256809339
COGS to revenue (%): 55.43931801393519
R&D to revenue (%): 8.244924035217313
SG&A to revenue (%): 31.22561839924934
Free cash flow (dilution-adjusted): 51661000
Buyback yield (%): 6.695235218032214
Retained earnings: 244406000
Inventory turnover: 22.567249085737505
Receivables turnover: 7.216395332084714
Capitalized R&D asset: 80801710
ROCI (R&D-adjusted, %): 3.4899493440512526
Rosenberg metric: 0.030073501930982932
FCF margin (%): 10.313841362374973
Revenue growth (%): -0.5928034024176535
Rule of 40 score: 9.72103795995732
Financial ratios for PRLB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 39.09
Shares outstanding: 23794045
Market cap (USD): 930109219.0500001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRLB — quarterly report dated 2025-03-31
Total revenue: 126205000
Gross profit: 55698000
Operating income: 4492000
Net income: 3599000
Capital expenditures: 1262000
Operating cash flow: 18379000
Depreciation & amortization: 8694000
Net tangible assets: 362035000
Owner earnings: 11031000
Return on net tangible assets (%): 3.046942975126714
Capex to operating income (%): 28.094390026714162
Buffett classification: The Good
Stock price: 35.04
P/E ratio: 57.91493031397611
Shares outstanding: 23794045
Book value: 656801000
P/B ratio: 1.2694002244210956
Market cap (USD): 833743336.8
Debt to equity: 0.004783792960120341
Current ratio: 3.1309991625330156
Quick ratio: 2.918379179282355
Effective tax rate (%): 39.86633249791144
COGS to revenue (%): 55.867041717840024
R&D to revenue (%): 8.40616457351135
SG&A to revenue (%): 32.16750524939582
Free cash flow (dilution-adjusted): 13125000
Buyback yield (%): 2.655253604180888
Retained earnings: 236554000
Inventory turnover: 5.3406302075443115
Receivables turnover: 1.68795473999572
Capitalized R&D asset: 10609000
ROCI (R&D-adjusted, %): 1.6858925672323402
FCF margin (%): 10.399746444277168
Rule of 40 score: 10.399746444277168
Financial ratios for PRLB — quarterly report dated 2025-06-30
Total revenue: 135063000
Gross profit: 59774000
Operating income: 5118000
Net income: 4427000
Capital expenditures: 1468000
Operating cash flow: 10584000
Depreciation & amortization: 8570000
Net tangible assets: 370216000
Owner earnings: 11529000
Return on net tangible assets (%): 3.1141279685372862
Capex to operating income (%): 28.683079327862448
Buffett classification: The Good
Stock price: 40.04
P/E ratio: 118.70340914527785
Shares outstanding: 23794045
Book value: 664707000
P/B ratio: 1.4332834794879548
Market cap (USD): 952713561.8
Debt to equity: 0.004256010542991123
Current ratio: 3.305868348240139
Quick ratio: 3.0940254809857795
Effective tax rate (%): 33.66796523823794
COGS to revenue (%): 55.74361594218994
R&D to revenue (%): 8.272435826244049
SG&A to revenue (%): 32.19460548040544
Free cash flow (dilution-adjusted): 4857000
Buyback yield (%): 0.520513216021693
Retained earnings: 239344000
Inventory turnover: 5.717138734907738
Receivables turnover: 1.706073314301594
Capitalized R&D asset: 18281030
ROCI (R&D-adjusted, %): 1.2912114986466205
Rosenberg metric: 0.38420209256291826
FCF margin (%): 3.596099597965394
Revenue growth (%): 7.018739352640544
Rule of 40 score: 10.614838950605938
Financial ratios for PRLB — quarterly report dated 2025-09-30
Total revenue: 135366000
Gross profit: 61293000
Operating income: 8851000
Net income: 7216000
Capital expenditures: 3251000
Operating cash flow: 29090000
Depreciation & amortization: 8429000
Net tangible assets: 371189000
Owner earnings: 12394000
Return on net tangible assets (%): 3.3389998087227797
Capex to operating income (%): 36.73031295898769
Buffett classification: The Good
Stock price: 50.03
P/E ratio: 78.10104129051305
Shares outstanding: 23794045
Book value: 664719000
P/B ratio: 1.7908560931009947
Market cap (USD): 1190416071.3500001
Debt to equity: 0.003675237205495856
Current ratio: 3.2375326202288432
Quick ratio: 3.035746035387571
Effective tax rate (%): 29.606867622670958
COGS to revenue (%): 54.72053543725899
R&D to revenue (%): 7.908189648803983
SG&A to revenue (%): 30.832705406084244
Free cash flow (dilution-adjusted): 21351000
Buyback yield (%): 1.071390105271028
Retained earnings: 238568000
Inventory turnover: 5.263483265828182
Receivables turnover: 1.6413769688739073
Capitalized R&D asset: 21691880
ROCI (R&D-adjusted, %): 1.2312274147999658
Rosenberg metric: 0.13595274322026313
FCF margin (%): 15.772793759141882
Revenue growth (%): 0.22433975255991648
Rule of 40 score: 15.997133511701799
Financial ratios for PRLB — annual report dated 2025-12-31
Total revenue: 533127000
Gross profit: 237137000
Operating income: 26201000
Net income: 21241000
Capital expenditures: 14008000
Operating cash flow: 74504000
Depreciation & amortization: 33814000
Net tangible assets: 381329000
Owner earnings: 41047000
Return on net tangible assets (%): 10.764195746979642
Capex to operating income (%): 53.463608259226746
Buffett classification: The Good
Stock price: 50.59
P/E ratio: 56.67062457276023
Shares outstanding: 23794045
Book value: 673932000
P/B ratio: 1.7861456891051324
Market cap (USD): 1203740736.5500002
Debt to equity: 0.004521227660950956
Current ratio: 3.4855825199247783
Quick ratio: 3.270648637354109
Effective tax rate (%): 31.617410340609105
COGS to revenue (%): 55.51960414685432
R&D to revenue (%): 8.029606453996891
SG&A to revenue (%): 31.536200567594584
Free cash flow (dilution-adjusted): 43933000
Buyback yield (%): 3.854401416452586
Retained earnings: 240764000
Inventory turnover: 20.553433789320184
Receivables turnover: 6.547300035614723
Capitalized R&D asset: 83722210
ROCI (R&D-adjusted, %): 3.537250079166833
Rosenberg metric: 0.3374739696837619
FCF margin (%): 8.240625592025914
Revenue growth (%): 6.4359440196450315
Rule of 40 score: 14.676569611670946
Financial ratios for PRLB — quarterly report dated 2025-12-31
Total revenue: 136493000
Gross profit: 60372000
Operating income: 7740000
Net income: 5999000
Capital expenditures: 8027000
Operating cash flow: 16451000
Depreciation & amortization: 8121000
Net tangible assets: 381329000
Owner earnings: 6093000
Return on net tangible assets (%): 1.5978328425060775
Capex to operating income (%): 103.70801033591732
Buffett classification: The Gruesome
Stock price: 50.59
P/E ratio: 56.67062457276023
Shares outstanding: 23794045
Book value: 673932000
P/B ratio: 1.7861456891051324
Market cap (USD): 1203740736.5500002
Debt to equity: 0.004521227660950956
Current ratio: 3.4855825199247783
Quick ratio: 3.270648637354109
Effective tax rate (%): 26.41069676153091
COGS to revenue (%): 55.769160323240015
R&D to revenue (%): 7.561559933476442
SG&A to revenue (%): 30.998659271904057
Free cash flow (dilution-adjusted): 4600000
Buyback yield (%): 0.5438048078991881
Retained earnings: 240764000
Inventory turnover: 5.285813485174641
Receivables turnover: 1.676262173480541
Capitalized R&D asset: 21180440
ROCI (R&D-adjusted, %): 1.0211910521367085
Rosenberg metric: -0.0860345632881831
FCF margin (%): 3.3701361974606754
Revenue growth (%): 0.832557658496225
Rule of 40 score: 4.2026938559569
Financial ratios for PVT.AX — annual report dated 2021-06-30
Operating income: -1547033.8345864662
Net income: -1497543.6090225563
Capital expenditures: 46793.23308270676
Depreciation & amortization: 23797.744360902256
Net tangible assets: 14849532.330827067
Owner earnings: -1520539.0977443608
Return on net tangible assets (%): -10.239642999313716
Buffett classification: The Gruesome
Stock price: 0.06766917293233082
Shares outstanding: 1313172494
Book value: 14849532.330827067
P/B ratio: 5.984114153008945
Market cap (USD): 88861296.58646616
Debt to equity: 0.003140221929472172
Current ratio: 9.276843422536373
Quick ratio: 9.276843422536373
Interest coverage ratio: -1041.2727732793524
Free cash flow (dilution-adjusted): -3449242.857142857
Buyback yield (%): 0.10361167373035152
Retained earnings: -4305142.857142857
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.396110266054993
Rule of 40 score: 0
Financial ratios for PVT.AX — annual report dated 2022-06-30
Operating income: -1471263.448275862
Net income: -1442893.103448276
Capital expenditures: 40053.10344827586
Depreciation & amortization: 65367.58620689655
Net tangible assets: 13341480
Owner earnings: -1417578.6206896554
Return on net tangible assets (%): -10.625347567808486
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 1313172494
Book value: 13341480
P/B ratio: 2.0364371930819236
Market cap (USD): 27169086.08275862
Debt to equity: 0.007772182231139533
Current ratio: 2.1412405414756384
Quick ratio: 2.1412405414756384
Interest coverage ratio: -408.13698105988135
Free cash flow (dilution-adjusted): -3228288.9655172415
Buyback yield (%): 0.17285111770954698
Retained earnings: -5391748.275862069
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.96098683682782
Rule of 40 score: 0
Financial ratios for PVT.AX — annual report dated 2023-06-30
Operating income: -12636917.218543047
Net income: -12617349.006622516
Capital expenditures: 74406.6225165563
Depreciation & amortization: 78932.45033112583
Net tangible assets: 8384744.370860927
Owner earnings: -12612823.178807946
Return on net tangible assets (%): -150.42585224948115
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 1313172494
Book value: 8384744.370860928
P/B ratio: 2.0743641542618714
Market cap (USD): 17393013.165562913
Debt to equity: 0.08291619816626916
Current ratio: 4.667134546246159
Quick ratio: 4.667134546246159
Interest coverage ratio: -505.2892966846733
Free cash flow (dilution-adjusted): -3978831.1258278145
Buyback yield (%): 1.1258117320876508
Retained earnings: -17794855.629139073
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -150.71320793582544
Rule of 40 score: 0
Financial ratios for PVT.AX — annual report dated 2024-06-30
Operating income: -1315435.3333333333
Net income: -1246587.3333333333
Capital expenditures: 59681.333333333336
Depreciation & amortization: 75953.33333333333
Net tangible assets: 8693132
Owner earnings: -1230315.3333333333
Return on net tangible assets (%): -14.152728076984605
Buffett classification: The Gruesome
Stock price: 0.013333333333333334
Shares outstanding: 1313172494
Book value: 8693132
P/B ratio: 2.0141148882435775
Market cap (USD): 17508966.586666666
Debt to equity: 0
Current ratio: 6.077380818357559
Quick ratio: 6.077380818357559
Interest coverage ratio: -77.18784962641317
Free cash flow (dilution-adjusted): -3790009.3333333335
Buyback yield (%): 0.7666433805154009
Retained earnings: -19160075.333333332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.131891858231686
Rule of 40 score: 0
Financial ratios for REDINGTON.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.626401160490571
Shares outstanding: 781774431
Market cap (USD): 1271478841.8202558
Buyback yield (%): 0
Retained earnings: 630816299.6175656
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REDINGTON.NS — annual report dated 2023-03-31
Total revenue: 9663432399.51279
Gross profit: 435695493.30085266
Operating income: 255649208.28258222
Net income: 175321559.07429963
Capital expenditures: 17522533.49573691
Operating cash flow: -393851400.7308161
Depreciation & amortization: 18928136.419001218
Net tangible assets: 796281364.1900122
Owner earnings: 176727161.99756396
Return on net tangible assets (%): 22.194059781536282
Capex to operating income (%): 6.854131727397469
Buffett classification: The Great
Stock price: 1.8181485992691842
P/E ratio: 8.107286372377883
Shares outstanding: 781774431
Book value: 888327649.2082825
P/B ratio: 1.6000651200420397
Market cap (USD): 1421382086.6671135
Debt to equity: 0.4553301239378762
Current ratio: 1.4160028809356133
Quick ratio: 0.9628017738478337
Effective tax rate (%): 21.49367047183755
Interest coverage ratio: 7.989645984012181
COGS to revenue (%): 95.49129672265498
SG&A to revenue (%): 0.6581310711122885
Free cash flow (dilution-adjusted): -413591961.0231425
Buyback yield (%): 0
Retained earnings: 689436053.5931791
Inventory turnover: 10.69258150018489
Receivables turnover: 6.594883645537633
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.438491907862055
FCF margin (%): -4.279969517290719
Rule of 40 score: -4.279969517290719
Financial ratios for REDINGTON.NS — annual report dated 2024-03-31
Total revenue: 10709896870.128313
Gross profit: 453620338.17004436
Operating income: 227191509.7733541
Net income: 148532198.10528842
Capital expenditures: 5429907.662789303
Operating cash flow: 129439980.81304713
Depreciation & amortization: 21717232.282048207
Net tangible assets: 856217771.9150977
Owner earnings: 164819522.7245473
Return on net tangible assets (%): 19.24971988795518
Capex to operating income (%): 2.3900134596606053
Buffett classification: The Great
Stock price: 2.3262955854126677
P/E ratio: 12.244068497085335
Shares outstanding: 781774431
Book value: 942792900.8274374
P/B ratio: 1.9289903498718344
Market cap (USD): 1818638407.6238003
Debt to equity: 0.37626924617938295
Current ratio: 1.429043944802771
Quick ratio: 1.0185802619190698
Effective tax rate (%): 21.340615374845203
Interest coverage ratio: 5.063746191265302
COGS to revenue (%): 95.76447519830684
SG&A to revenue (%): 0.7467599031372022
Free cash flow (dilution-adjusted): 114803933.32533877
Buyback yield (%): 0
Retained earnings: 757414558.1004916
Inventory turnover: 12.855764923746623
Receivables turnover: 6.409314946197822
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.144828192820828
FCF margin (%): 1.0719424726259137
Revenue growth (%): 10.829117722894019
Rule of 40 score: 11.901060195519932
Financial ratios for REDINGTON.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 860108695.6521739
Buffett classification: The Gruesome
Stock price: 2.111442904921166
Shares outstanding: 781774431
Book value: 938908265.6473961
P/B ratio: 1.758075986737171
Market cap (USD): 1650672075.5837314
Debt to equity: 0.2193793301732451
Current ratio: 1.3730823908614256
Quick ratio: 1.0111376922522584
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REDINGTON.NS — quarterly report dated 2024-12-31
Total revenue: 3114125189.4160156
Gross profit: 124191630.72619185
Operating income: 63936356.2186735
Net income: 46970509.383378014
Capital expenditures: 0
Depreciation & amortization: 6293274.2743909545
Owner earnings: 53263783.657768965
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2323114582119126
P/E ratio: 9.288615574797126
Shares outstanding: 781774431
Market cap (USD): 1745164020.0583982
Effective tax rate (%): 21.43191389798783
Interest coverage ratio: 6.531436056203858
COGS to revenue (%): 96.01198978293222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for REDINGTON.NS — quarterly report dated 2025-03-31
Total revenue: 3090914192.190788
Gross profit: 119583820.43488425
Operating income: 65275894.31844751
Net income: 107287818.56441431
Capital expenditures: 0
Depreciation & amortization: 7375496.843581949
Net tangible assets: 976855272.3871872
Owner earnings: 114663315.40799625
Return on net tangible assets (%): 11.738004456667168
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.7138522581398066
P/E ratio: 4.943758604923814
Shares outstanding: 781774431
Book value: 1075192892.214169
P/B ratio: 1.9732462149709822
Market cap (USD): 2121620304.9253125
Debt to equity: 0.30536685078067227
Current ratio: 1.4552256984808791
Quick ratio: 1.1063922701689803
Effective tax rate (%): 20.067239186858746
Interest coverage ratio: 6.846965052115267
COGS to revenue (%): 96.13111807707203
Buyback yield (%): 0
Retained earnings: 869327799.8597147
Inventory turnover: 4.043044345538244
Receivables turnover: 1.5256164136155412
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.839126761034702
Revenue growth (%): -0.7453456689575326
Rule of 40 score: -0.7453456689575326
Financial ratios for REDINGTON.NS — annual report dated 2025-03-31
Total revenue: 11607522796.352583
Gross profit: 445007014.2623334
Operating income: 239652794.01449612
Net income: 212838438.15758708
Capital expenditures: 14942716.857610473
Operating cash flow: 34208557.40004676
Depreciation & amortization: 25436053.30839373
Net tangible assets: 976855272.3871872
Owner earnings: 223331774.60837036
Return on net tangible assets (%): 22.862319621063616
Capex to operating income (%): 6.23515236659691
Buffett classification: The Great
Stock price: 2.7138522581398066
P/E ratio: 9.968219666009999
Shares outstanding: 781774431
Book value: 1075192892.214169
P/B ratio: 1.9732462149709822
Market cap (USD): 2121620304.9253125
Debt to equity: 0.30536685078067227
Current ratio: 1.4552256984808791
Quick ratio: 1.1063922701689803
Effective tax rate (%): 22.02277701397544
Interest coverage ratio: 6.44468546637744
COGS to revenue (%): 96.16621890760217
SG&A to revenue (%): 0.6400294085803562
Free cash flow (dilution-adjusted): 15133270.984334813
Buyback yield (%): 0
Retained earnings: 869327799.8597147
Inventory turnover: 15.188666579708393
Receivables turnover: 5.729252317735967
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.437669410701734
FCF margin (%): 0.13037468243517147
Revenue growth (%): 8.381275161742202
Rule of 40 score: 8.511649844177374
Financial ratios for REDINGTON.NS — quarterly report dated 2025-06-30
Total revenue: 3036741165.4575243
Gross profit: 105361572.66557455
Operating income: 40535923.2389422
Net income: 32210390.826117486
Capital expenditures: 0
Depreciation & amortization: 6297683.126608941
Owner earnings: 38508073.952726424
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.6441610109992983
P/E ratio: 15.278229611802177
Shares outstanding: 781774431
Market cap (USD): 2848911900.846361
Effective tax rate (%): 23.444944632471326
Interest coverage ratio: 3.781052172014844
COGS to revenue (%): 96.53043947689561
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.7526538546470152
Rule of 40 score: -1.7526538546470152
Financial ratios for REDINGTON.NS — quarterly report dated 2025-12-31
Total revenue: 3444550517.9904203
Gross profit: 122674612.8996324
Operating income: 65540826.55675616
Net income: 48546284.95042887
Capital expenditures: 0
Depreciation & amortization: 5211095.020608221
Owner earnings: 53757379.9710371
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.9686977832237944
P/E ratio: 9.8753355467168
Shares outstanding: 781774431
Market cap (USD): 2320852020.2907434
Effective tax rate (%): 23.13027632117223
Interest coverage ratio: 7.487401374395521
COGS to revenue (%): 96.43858865593872
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 13.429177210480312
Rule of 40 score: 13.429177210480312
Financial ratios for RXT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.47
Shares outstanding: 253908600
Market cap (USD): 3420148842
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RXT — annual report dated 2022-12-31
Total revenue: 3122300000
Gross profit: 856900000
Operating income: 1600000
Net income: -804800000
Capital expenditures: 80400000
Operating cash flow: 246700000
Depreciation & amortization: 447500000
Net tangible assets: -2761600000
Owner earnings: -437700000
Capex to operating income (%): 5025
Buffett classification: The Gruesome
Stock price: 2.95
Shares outstanding: 253908600
Book value: 629500000
P/B ratio: 1.1898814455917397
Market cap (USD): 749030370
Debt to equity: 6.119301032565528
Current ratio: 1.2530064214827787
Quick ratio: 1.2530064214827787
Interest coverage ratio: 0.007673860911270983
COGS to revenue (%): 72.55548794158153
SG&A to revenue (%): 27.393267783364827
Free cash flow (dilution-adjusted): 96800000
Buyback yield (%): 4.138683989542373
Retained earnings: -1986400000
Receivables turnover: 5.018161362905818
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.034781096474066346
FCF margin (%): 3.100278640745604
Rule of 40 score: 3.100278640745604
Financial ratios for RXT — annual report dated 2023-12-31
Total revenue: 2957100000
Gross profit: 628800000
Operating income: -138400000
Net income: -837800000
Capital expenditures: 96900000
Operating cash flow: 374900000
Depreciation & amortization: 442900000
Net tangible assets: -2625900000
Owner earnings: -491800000
Buffett classification: The Gruesome
Stock price: 2
Shares outstanding: 253908600
Book value: -154500000
Market cap (USD): 507817200
Debt to equity: -21.883495145631066
Current ratio: 0.9232020012507818
Quick ratio: 0.9232020012507818
Interest coverage ratio: -0.6245487364620939
COGS to revenue (%): 78.73592370903926
SG&A to revenue (%): 25.944337357546242
Free cash flow (dilution-adjusted): 212600000
Buyback yield (%): 0.19692125434112906
Retained earnings: -2824200000
Receivables turnover: 8.705033853400058
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.198137531470865
FCF margin (%): 7.189476175983227
Revenue growth (%): -5.290971399288986
Rule of 40 score: 1.8985047766942413
Financial ratios for RXT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.45
Shares outstanding: 253908600
Market cap (USD): 622076070
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RXT — annual report dated 2024-12-31
Total revenue: 2737100000
Gross profit: 533400000
Operating income: -174200000
Net income: -858200000
Capital expenditures: 111100000
Operating cash flow: 39900000
Depreciation & amortization: 363000000
Net tangible assets: -2584600000
Owner earnings: -606300000
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 253908600
Book value: -1004200000
Market cap (USD): 561138006
Debt to equity: -3.268173670583549
Current ratio: 0.8072006261414036
Quick ratio: 0.8072006261414036
Interest coverage ratio: -1.7775510204081633
COGS to revenue (%): 80.5122209637938
SG&A to revenue (%): 25.852179313872348
Free cash flow (dilution-adjusted): -134600000
Buyback yield (%): 0.7662999037709095
Retained earnings: -3682400000
Receivables turnover: 9.160307898259706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.615300546448088
FCF margin (%): -4.917613532570969
Revenue growth (%): -7.439721348618579
Rule of 40 score: -12.357334881189548
Financial ratios for RXT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.21
Shares outstanding: 253908600
Market cap (USD): 561138006
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RXT — quarterly report dated 2025-03-31
Total revenue: 665400000
Gross profit: 126900000
Operating income: -38400000
Net income: -71500000
Capital expenditures: 8300000
Operating cash flow: 12600000
Depreciation & amortization: 73900000
Net tangible assets: -2617900000
Owner earnings: -5900000
Buffett classification: The Gruesome
Stock price: 1.69
Shares outstanding: 253908600
Book value: -1073100000
Market cap (USD): 429105534
Debt to equity: -3.07166154132886
Current ratio: 0.7917800762112139
Quick ratio: 0.7917800762112139
Interest coverage ratio: -1.9793814432989691
COGS to revenue (%): 80.9287646528404
SG&A to revenue (%): 24.84220018034265
Free cash flow (dilution-adjusted): -7700000
Buyback yield (%): 0
Retained earnings: -3753900000
Receivables turnover: 2.4736059479553902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.7209698382109082
FCF margin (%): -1.1571986774872258
Rule of 40 score: -1.1571986774872258
Financial ratios for RXT — quarterly report dated 2025-06-30
Total revenue: 666300000
Gross profit: 129200000
Operating income: -25100000
Net income: -54500000
Capital expenditures: 20800000
Operating cash flow: 8400000
Depreciation & amortization: 75000000
Net tangible assets: -2630300000
Owner earnings: -300000
Buffett classification: The Gruesome
Stock price: 1.28
Shares outstanding: 253908600
Book value: -1119000000
Market cap (USD): 325003008
Debt to equity: -2.940750670241287
Current ratio: 0.7665641599105396
Quick ratio: 0.7665641599105396
Interest coverage ratio: -1.1784037558685445
COGS to revenue (%): 80.60933513432389
SG&A to revenue (%): 23.157736755215367
Free cash flow (dilution-adjusted): -22400000
Buyback yield (%): 0.24615156792641132
Retained earnings: -3808400000
Receivables turnover: 2.6242615202835764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.1516402844689149
FCF margin (%): -3.3618490169593276
Revenue growth (%): 0.1352569882777277
Rule of 40 score: -3.2265920286816
Financial ratios for RXT — quarterly report dated 2025-09-30
Total revenue: 671200000
Gross profit: 129900000
Operating income: -33900000
Net income: -67100000
Capital expenditures: 28000000
Operating cash flow: 70700000
Depreciation & amortization: 198600000
Net tangible assets: -2659600000
Owner earnings: 103500000
Buffett classification: The Gruesome
Stock price: 1.41
Shares outstanding: 253908600
Book value: -1187200000
Market cap (USD): 358011126
Debt to equity: -2.735427897574124
Current ratio: 0.7059514487079092
Quick ratio: 0.7059514487079092
Interest coverage ratio: -1.599056603773585
COGS to revenue (%): 80.6466030989273
SG&A to revenue (%): 24.404052443384984
Free cash flow (dilution-adjusted): 24500000
Buyback yield (%): 0.33518511377213456
Retained earnings: -3875500000
Receivables turnover: 2.4505293902884264
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6307485087550508
FCF margin (%): 3.6501787842669846
Revenue growth (%): 0.735404472459853
Rule of 40 score: 4.385583256726838
Financial ratios for RXT — annual report dated 2025-12-31
Total revenue: 2685700000
Gross profit: 506400000
Operating income: -100700000
Net income: -225800000
Capital expenditures: 60800000
Operating cash flow: 151400000
Depreciation & amortization: 362600000
Net tangible assets: -2657900000
Owner earnings: 76000000
Buffett classification: The Gruesome
Stock price: 0.97
Shares outstanding: 253908600
Book value: -1219500000
Market cap (USD): 246291342
Debt to equity: -2.66059860598606
Current ratio: 0.6753619407851833
Quick ratio: 0.6753619407851833
Interest coverage ratio: -1.2176541717049576
COGS to revenue (%): 81.14458055627955
SG&A to revenue (%): 22.60490747291209
Free cash flow (dilution-adjusted): 45500000
Buyback yield (%): 0.8120464096541404
Retained earnings: -3908200000
Receivables turnover: 10.07767354596623
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.953027396586494
FCF margin (%): 1.6941579476486577
Revenue growth (%): -1.877899967118483
Rule of 40 score: -0.18374201946982538
Financial ratios for RXT — quarterly report dated 2025-12-31
Total revenue: 682800000
Gross profit: 120400000
Operating income: -3300000
Net income: -32700000
Capital expenditures: 3700000
Operating cash flow: 59700000
Depreciation & amortization: 90100000
Net tangible assets: -2657900000
Owner earnings: 53700000
Buffett classification: The Gruesome
Stock price: 0.97
Shares outstanding: 253908600
Book value: -1219500000
Market cap (USD): 246291342
Debt to equity: -2.66059860598606
Current ratio: 0.6753619407851833
Quick ratio: 0.6753619407851833
Interest coverage ratio: -0.15865384615384615
COGS to revenue (%): 82.36672524897482
SG&A to revenue (%): 18.116578793204454
Free cash flow (dilution-adjusted): 51100000
Buyback yield (%): 0
Retained earnings: -3908200000
Receivables turnover: 2.5621013133208255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.1623137081304412
FCF margin (%): 7.483889865260691
Revenue growth (%): 1.7282479141835518
Rule of 40 score: 9.212137779444243
Financial ratios for SBAC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 360.81
Shares outstanding: 106063017
Market cap (USD): 38268597163.77
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBAC — annual report dated 2022-12-31
Total revenue: 2633454000
Gross profit: 1964804000
Operating income: 995375000
Net income: 461429000
Capital expenditures: 214443000
Operating cash flow: 1285700000
Depreciation & amortization: 707576000
Net tangible assets: -8052787000
Owner earnings: 954562000
Return on net tangible assets (%): -11.853809122233084
Capex to operating income (%): 21.543940725857087
Buffett classification: The Great
Stock price: 262.31
P/E ratio: 60.2939780318749
Shares outstanding: 106063017
Book value: -5244580000
Market cap (USD): 27821389989.27
Debt to equity: -2.8927302090920533
Current ratio: 0.6928213857202725
Quick ratio: 0.6928213857202725
Effective tax rate (%): 12.559642326702075
Interest coverage ratio: 2.4891033351421505
COGS to revenue (%): 25.390608683500833
SG&A to revenue (%): 9.943329179093311
Free cash flow (dilution-adjusted): 971348000
Buyback yield (%): 1.5515615868455264
Retained earnings: -7482061000
Receivables turnover: 9.958380917087043
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.066212748692214
FCF margin (%): 36.88494274059847
Rule of 40 score: 36.88494274059847
Financial ratios for SBAC — annual report dated 2023-12-31
Total revenue: 2711584000
Gross profit: 2098962000
Operating income: 1114717000
Net income: 501812000
Capital expenditures: 236698000
Operating cash flow: 1544393000
Depreciation & amortization: 716309000
Net tangible assets: -7626479000
Owner earnings: 981423000
Return on net tangible assets (%): -12.868625220104848
Capex to operating income (%): 21.233909593197197
Buffett classification: The Great
Stock price: 240.92
P/E ratio: 50.92086688967183
Shares outstanding: 106063017
Book value: -5135835000
Market cap (USD): 25552702055.64
Debt to equity: -2.816185683535394
Current ratio: 0.35522743660595674
Quick ratio: 0.35522743660595674
Effective tax rate (%): 9.314078500938008
Interest coverage ratio: 2.5552779312352576
COGS to revenue (%): 22.59277234266023
SG&A to revenue (%): 9.881161712121035
Free cash flow (dilution-adjusted): 1219776000
Buyback yield (%): 0.39138718004159473
Retained earnings: -7450824000
Receivables turnover: 13.415315199430058
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.645422408748905
FCF margin (%): 44.983891334363975
Revenue growth (%): 2.9668260770835566
Rule of 40 score: 47.95071741144753
Financial ratios for SBAC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 231.78
Shares outstanding: 106063017
Market cap (USD): 24583286080.26
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBAC — annual report dated 2024-12-31
Total revenue: 2679634000
Gross profit: 2097907000
Operating income: 1569634000
Net income: 749536000
Capital expenditures: 228149000
Operating cash flow: 1334866000
Depreciation & amortization: 269517000
Net tangible assets: -7498645000
Owner earnings: 790904000
Return on net tangible assets (%): -10.54729221079275
Capex to operating income (%): 14.53517189357519
Buffett classification: The Great
Stock price: 197.14
P/E ratio: 27.89627605796119
Shares outstanding: 106063017
Book value: -5055806000
Market cap (USD): 20909263171.379997
Debt to equity: -3.116455417790952
Current ratio: 1.100550853867991
Quick ratio: 1.100550853867991
Effective tax rate (%): 3.1047050083736054
Interest coverage ratio: 3.672182463462623
COGS to revenue (%): 21.709196106632472
SG&A to revenue (%): 9.656393373124837
Free cash flow (dilution-adjusted): 1032343000
Buyback yield (%): 0.956604727582081
Retained earnings: -7326189000
Receivables turnover: 9.417656299972235
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.31737946233653
FCF margin (%): 38.525522515388296
Revenue growth (%): -1.178278083953881
Rule of 40 score: 37.34724443143442
Financial ratios for SBAC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 197.14
Shares outstanding: 106063017
Market cap (USD): 20909263171.379997
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SBAC — quarterly report dated 2025-03-31
Total revenue: 664248000
Gross profit: 510582000
Operating income: 379315000
Net income: 220732000
Capital expenditures: 46173000
Operating cash flow: 301175000
Depreciation & amortization: 65048000
Net tangible assets: -7373749000
Owner earnings: 239607000
Return on net tangible assets (%): -3.2494596710574224
Capex to operating income (%): 12.172732425556596
Buffett classification: The Great
Stock price: 213.91
P/E ratio: 25.696251525005433
Shares outstanding: 106063017
Book value: -4908099000
Market cap (USD): 22687939966.47
Debt to equity: -2.9830555577627917
Current ratio: 0.694940343227482
Quick ratio: 0.694940343227482
Effective tax rate (%): 16.165817062614217
Interest coverage ratio: 3.3718087754231263
COGS to revenue (%): 23.13382953354771
SG&A to revenue (%): 9.9690175958377
Free cash flow (dilution-adjusted): 239289000
Buyback yield (%): 0
Retained earnings: -7226216000
Receivables turnover: 4.198069861654458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.1683420511937435
FCF margin (%): 36.02404523611663
Rule of 40 score: 36.02404523611663
Financial ratios for SBAC — quarterly report dated 2025-06-30
Total revenue: 698981000
Gross profit: 526885000
Operating income: 385899000
Net income: 225794000
Capital expenditures: 55865000
Operating cash flow: 368098000
Depreciation & amortization: 69964000
Net tangible assets: -7518701000
Owner earnings: 239893000
Return on net tangible assets (%): -3.190617634615341
Capex to operating income (%): 14.476585842409543
Buffett classification: The Great
Stock price: 229.43
P/E ratio: 54.496351814474416
Shares outstanding: 106063017
Book value: -4873738000
Market cap (USD): 24334037990.31
Debt to equity: -3.0378582106793592
Current ratio: 0.36637488153150477
Quick ratio: 0.36637488153150477
Effective tax rate (%): 13.44529113758998
Interest coverage ratio: 3.1921234831377028
COGS to revenue (%): 24.620983975243963
SG&A to revenue (%): 10.160791208916981
Free cash flow (dilution-adjusted): 290717000
Buyback yield (%): 0.5370912959536109
Retained earnings: -7251106000
Receivables turnover: 3.687094817354609
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.13314922795914
FCF margin (%): 41.59154540681364
Revenue growth (%): 5.228920523659838
Rule of 40 score: 46.820465930473475
Financial ratios for SBAC — quarterly report dated 2025-09-30
Total revenue: 732327000
Gross profit: 542538000
Operating income: 399647000
Net income: 240431000
Capital expenditures: 60053000
Operating cash flow: 318030000
Depreciation & amortization: 76883000
Net tangible assets: -7659028000
Owner earnings: 257261000
Return on net tangible assets (%): -3.3589249184100125
Capex to operating income (%): 15.026510895865602
Buffett classification: The Great
Stock price: 189.84
P/E ratio: 29.3104272134646
Shares outstanding: 106063017
Book value: -4857378000
Market cap (USD): 20135003147.28
Debt to equity: -3.091488041490697
Current ratio: 0.5043700433528164
Quick ratio: 0.5043700433528164
Effective tax rate (%): 16.82976861316646
Interest coverage ratio: 3.310501072721399
COGS to revenue (%): 25.91601839069159
SG&A to revenue (%): 9.01345983419975
Free cash flow (dilution-adjusted): 238654000
Buyback yield (%): 0.7491183333655252
Retained earnings: -7284980000
Receivables turnover: 3.345471240423753
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.141732572336294
FCF margin (%): 32.58844751047005
Revenue growth (%): 4.770659002176025
Rule of 40 score: 37.35910651264607
Financial ratios for SBAC — annual report dated 2025-12-31
Total revenue: 2815139000
Gross profit: 2124167000
Operating income: 1554271000
Net income: 1054456000
Capital expenditures: 224819000
Operating cash flow: 1291328000
Depreciation & amortization: 292285000
Net tangible assets: -7735636000
Owner earnings: 1121922000
Return on net tangible assets (%): -14.503293588271216
Capex to operating income (%): 14.464594655629554
Buffett classification: The Great
Stock price: 190.97
P/E ratio: 19.208818913724233
Shares outstanding: 106063017
Book value: -4775257000
Market cap (USD): 20254854356.49
Debt to equity: -3.2080221022659097
Current ratio: 0.2887767282318156
Quick ratio: 0.2887767282318156
Effective tax rate (%): 15.102758530737384
Interest coverage ratio: 3.2600221911331952
COGS to revenue (%): 24.544862616020026
SG&A to revenue (%): 9.861360309384368
Free cash flow (dilution-adjusted): 990775000
Buyback yield (%): 2.4577071315276813
Retained earnings: -7249905000
Receivables turnover: 10.671570671498646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.470175214188703
FCF margin (%): 35.19453213500292
Revenue growth (%): 5.056847315715504
Rule of 40 score: 40.251379450718424
Financial ratios for SBAC — quarterly report dated 2025-12-31
Total revenue: 719583000
Gross profit: 544163000
Operating income: 389410000
Net income: 370425000
Capital expenditures: 62728000
Operating cash flow: 304025000
Depreciation & amortization: 80391000
Net tangible assets: -7735636000
Owner earnings: 388088000
Return on net tangible assets (%): -5.016885489441333
Capex to operating income (%): 16.10847179065766
Buffett classification: The Great
Stock price: 190.97
P/E ratio: 19.155664042408514
Shares outstanding: 106063017
Book value: -4775257000
Market cap (USD): 20254854356.49
Debt to equity: -3.2080221022659097
Current ratio: 0.2887767282318156
Quick ratio: 0.2887767282318156
Effective tax rate (%): 14.3084179819884
Interest coverage ratio: 3.174710582096853
COGS to revenue (%): 24.378007818417053
SG&A to revenue (%): 10.334040687453706
Free cash flow (dilution-adjusted): 222115000
Buyback yield (%): 1.0677637873545218
Retained earnings: -7249905000
Receivables turnover: 2.7277803470837534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.37701078522164
FCF margin (%): 30.867182798926603
Revenue growth (%): -1.74020621935283
Rule of 40 score: 29.12697657957377
Financial ratios for SCE.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.782608695652174
Shares outstanding: 3770713
Market cap (USD): 40658122.782608695
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCE.DE — annual report dated 2022-12-31
Total revenue: 139411702.1276596
Gross profit: -6772340.425531915
Operating income: -24719148.936170213
Net income: -31477659.574468087
Capital expenditures: 12045744.680851065
Operating cash flow: -3807446.8085106383
Depreciation & amortization: 12984042.55319149
Net tangible assets: -7638297.872340426
Owner earnings: -30539361.70212766
Buffett classification: The Gruesome
Stock price: 10.782608695652174
Shares outstanding: 3770713
Book value: -9352127.659574479
Market cap (USD): 40658122.782608695
Debt to equity: -3.3265840063701475
Current ratio: 0.9610346321789274
Quick ratio: 0.8588880370654312
Interest coverage ratio: -4.904178978471929
COGS to revenue (%): 104.85779911024287
SG&A to revenue (%): 14.978595465748928
Free cash flow (dilution-adjusted): -15853191.489361703
Buyback yield (%): 0
Retained earnings: -40393617.0212766
Inventory turnover: 11.210066895088922
Receivables turnover: 11.268013757523645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -57.67903686235574
FCF margin (%): -11.371492670568575
Rule of 40 score: -11.371492670568575
Financial ratios for SCE.DE — annual report dated 2023-12-31
Total revenue: 154932222.2222222
Gross profit: 19514444.444444444
Operating income: -1806666.6666666665
Net income: 38760000
Capital expenditures: 1033333.3333333333
Operating cash flow: 11001111.11111111
Depreciation & amortization: 5015555.555555555
Net tangible assets: 31903333.333333332
Owner earnings: 42742222.22222222
Return on net tangible assets (%): 133.9741580468777
Buffett classification: The Gruesome
Stock price: 10.782608695652174
P/E ratio: 1.048971176021896
Shares outstanding: 3770713
Book value: 32578888.888888896
P/B ratio: 1.2479898538367662
Market cap (USD): 40658122.782608695
Debt to equity: 0.8270522833464068
Current ratio: 1.722563155386082
Quick ratio: 1.3956148713060057
Effective tax rate (%): 2.085496954556937
Interest coverage ratio: -0.43569131832797425
COGS to revenue (%): 87.40452814492359
SG&A to revenue (%): 14.863130114243505
Free cash flow (dilution-adjusted): 9967777.777777778
Buyback yield (%): 0
Retained earnings: -2272222.222222222
Inventory turnover: 11.104874715261959
Receivables turnover: 5.411744158969184
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.1372520669304276
FCF margin (%): 6.433637648003787
Revenue growth (%): 11.1328675123344
Rule of 40 score: 17.56650516033819
Financial ratios for SCE.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.311111111111111
Shares outstanding: 3770713
Market cap (USD): 16255962.71111111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCE.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.6458333333333335
Shares outstanding: 3770713
Market cap (USD): 9976678.145833334
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SCE.DE — annual report dated 2024-12-31
Total revenue: 150569791.6666667
Gross profit: 10148958.333333334
Operating income: -6543750
Net income: -9423958.333333334
Capital expenditures: 518750
Operating cash flow: 7285416.666666667
Depreciation & amortization: 6227083.333333334
Net tangible assets: 21914583.333333336
Owner earnings: -3715625
Return on net tangible assets (%): -16.955033748455175
Buffett classification: The Gruesome
Stock price: 2.6458333333333335
Shares outstanding: 3770713
Book value: 22467708.33333333
P/B ratio: 0.44404520469191905
Market cap (USD): 9976678.145833334
Debt to equity: 1.0060735314571843
Current ratio: 1.353866442872557
Quick ratio: 1.0803980338088957
Interest coverage ratio: -2.713606911447084
COGS to revenue (%): 93.25963181525732
SG&A to revenue (%): 12.12131694189433
Free cash flow (dilution-adjusted): 5881250
Buyback yield (%): 0
Retained earnings: -10207291.666666668
Inventory turnover: 11.819728189390618
Receivables turnover: 6.235311879906825
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.3441462209781
FCF margin (%): 3.905995973627954
Revenue growth (%): -2.81570256527942
Rule of 40 score: 1.090293408348534